Breakthroughs in MASH Diagnosis and Management:
A Liver Connect City Series
Join us for one of 15 nationwide meetings! Stay at the forefront of liver health advancements and earn up to 3.0 AMA PRA Category 1 Credits! Registration is complimentary.
Liver Connect City Series: Chicago
Thursday, September 26 | 6:00 PM
The Emily Hotel
Nancy Reau, MD, Steven Flamm, MD, Sujit Janardhan, MD, PhD, and Allison Moser, NP
Liver Connect City Series: San Francisco
Saturday, November 2 | 8:00 AM
The Park James Hotel (Menlo Park)
Robert Wong, MD, MS, Marina Roytman, MD, and Edward Holt, MD
Liver Connect City Series: Pasadena
Saturday, November 2 | 8:00 AM
Le Méridien Pasadena Arcadia
Sammy Saab, MD, AGAF, MPH, Mazen Noureddin, MD, MHSc, and Norah Terrault, MD, MPH
Liver Connect City Series: Denver
Saturday, November 9 | 8:00 AM
Halcyon Hotel, Cherry Creek
Marcelo Kugelmas, MD, Kimberly Brown, MD, and Christina Hanson, FNP
Liver Connect City Series: Cleveland
Wednesday, January 15 | 6:00 PM
TO BE ANNOUNCED
Pierre Gholam, MD, William Carey, MD, and Adrian Lindsey, MD
Liver Connect City Series: Dallas
Thursday, January 16 | 6:00 PM
TO BE ANNOUNCED
Mack Mitchell, MD, Nadege Gunn, MD, CPI, and Lisa VanWagner, MD
Liver Connect City Series: Scottsdale
Thursday, January 23 | 6:00 PM
Hotel Valley Ho
Naim Alkhouri, MD, Ray Kim, MD, MBA, and Justin Reynolds, MD
Liver Connect City Series: Fort Lauderdale
Saturday, January 25 | 8:00 AM
Hotel Colonnade (Coral Gables)
Paul Martin, MD, Binu V. John, MD, MPH, and Ira Jacobson, MD
Liver Connect City Series: Houston
Saturday, February 8 | 8:00 AM
Houston Marriott West Loop
Mazen Noureddin, MD, MHSc, Rashmee Patil, MD, and Grace Su, MD
More Cities Coming Soon!
ACCREDITATION
Program Overview and Target Audience
The joint providers of Medical Education Resources (MER), the Chronic Liver Disease Foundation (CLDF), Gastroenterology and Hepatology Advanced Practice Providers (GHAPP), and the Global NASH Council (GNC) present Breakthroughs in MASH Diagnosis and Management: A Liver Connect City Series. This accredited series is designed to meet the educational needs of gastroenterologists, hepatologists, nurse practitioners (NPs), and physician assistants (PAs) who are currently managing and treating patients with metabolic dysfunction-associated steatohepatitis (MASH).
Educational Objectives
-
Assess the epidemiologic impact of the spectrum of SLD and MASLD
-
Discuss the Use of NITs in MASLD Risk Stratification and Monitoring in clinical practice
-
Explain initial treatment of MASLD with Lifestyle Modification and approved medication to manage cardio-metabolic risks (obesity and type 2 diabetes)
-
Review data on the currently approved medication for MASH
-
Review data about the most promising drugs in Phase 2 and 3 clinical trials of MASH
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER), the Chronic Liver Disease Foundation (CLDF), Gastroenterology and Hepatology Advanced Practice Providers (GHAPP), and the Global NASH Council (GNC). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit
Medical Education Resources designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
MER, CLDF, GHAPP, and GNC planners have no relevant financial relationships to disclose.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the Chronic Liver Disease Foundation, Gastroenterology and Hepatology Advanced Practice Providers, and the Global NASH Council, and/or Madrigal Pharmaceuticals. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Fee information
There is no fee for this educational activity.
Jointly provided by Medical Education Resources, the Chronic Liver Disease Foundation, Gastroenterology and Hepatology Advanced Practice Providers, and the Global NASH Council.
Supported by an educational grant from Madrigal Pharmaceuticals.
